Archive: November 2018
Hepatitis C
Care of Patients Following Cure of Hepatitis C Virus Infection
Norah A. Terrault, MD, MPH
Abstract: The vast majority of persons with chronic hepatitis C virus (HCV) infection will achieve virologic cure with the current direct-acting antiviral therapies. Prevention of […]
Gastroparesis
Current and Emerging Therapeutic Options for Gastroparesis
Aung S. Myint, DO, Brandon Rieders, MD, Mohammed Tashkandi, MD, Marie L. Borum, MD, EdD, MPH, Joyce M. Koh, MD, Sindu Stephen, MD, and David B. Doman, MD
Abstract: Gastroparesis is a complex, debilitating dysmotility disorder with challenging symptom management. A diagnosis of gastroparesis is based on objectively delayed gastric emptying in the […]
Diarrhea
Use and Interpretation of Enteropathogen Multiplex Nucleic Acid Amplification Tests in Patients With Suspected Infectious Diarrhea
Harika Yalamanchili, DO, Dima Dandachi, MD, and Pablo C. Okhuysen, MD
Abstract: Acute diarrheal illness due to gastrointestinal infection is a significant cause of morbidity and mortality in the United States and around the world. Determining […]
IBS
Highlights of the Updated Evidence-Based IBS Treatment Monograph
Eamonn M. M. Quigley, MD
G&H Why was an update to the monograph on the management of irritable bowel syndrome necessary? EQ An update to the monograph on the management […]
IBD
The Development of Patient-Reported Outcome Measures in Inflammatory Bowel Disease
Peter D. R. Higgins, MD, PhD, MSc
G&H What patient-reported outcome measures have traditionally been used in inflammatory bowel disease? PH To some extent, every patient visit involves a physician asking the patient […]
Hepatology
Use of Obeticholic Acid in Patients With Primary Biliary Cholangitis
Robert S. Brown Jr, MD, MPH
G&H Why was there a need for a treatment option in addition to ursodeoxycholic acid for patients with primary biliary cholangitis? RB Many primary biliary […]
HCC
Treatment of Hepatocellular Carcinoma With Lenvatinib
Kwang-Hyub Han, MD
G&H What is the mechanism of action of lenvatinib? K-HH Lenvatinib (Lenvima, Eisai) is a tyrosine kinase inhibitor selectively targeting vascular endothelial growth factor receptor […]
Endoscopy
A Comprehensive Approach to Preventing Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography
Timothy B. Gardner, MD, MS
G&H How often does pancreatitis develop following endoscopic retrograde cholangiopancreatography? TG Approximately 3% to 5% of patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) develop pancreatitis following […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
Same-Day Bowel Preparation Ideal for Afternoon Colonoscopies Same-day bowel preparation provides better cleansing and is preferred over a split-dose regimen for patients scheduled for an afternoon […]
Letter From the Editor
Letter from the Editor: Management of Patients After Being Cured of Hepatitis C Virus Infection
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
As physicians, our goal is to treat patients as best we can, which hopefully results in curing them whenever possible. But once they are cured, […]